Article
Circulating levels of Irisin in obese individuals at genetic risk for Alzheimer's disease: Correlations with amyloid-β, metabolic, and neurocognitive indices.
Behavioural brain research - 26 Feb 2021
Tsai Chia-Liang, Pai Ming-Chyi
Abstract excerpt
Irisin is involved in various metabolic pathways and is suggested to be a potential agent capable of preventing onset of Alzheimer's disease (AD) and ameliorating AD neuropathology and cognitive deficits. In the present study, the serum levels of Irisin and Amyloid-β (Aβ) peptides and the neurocognitive performance among obese individuals at genetic risk for AD were investigated. The correlations between Irisin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
